Anupam Rama
Stock Analyst at J.P. Morgan
(4.92)
# 212
Out of 4,531 analysts
751
Total ratings
55.7%
Success rate
25.2%
Average return
Main Sectors:
Stocks Rated by Anupam Rama
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KARD Kardigan | Initiated Coverage: Buy | $51 | $21.13 | +141.36% | 1 | Jul 13, 2026 | |
| TRAX First Tracks Biotherapeutics | Reiterated: Buy | $30 | $36.52 | -17.84% | 3 | Jul 9, 2026 | |
| RARE Ultragenyx Pharmaceutical | Maintained: Buy | $72 | $29.28 | +145.90% | 29 | Jul 7, 2026 | |
| REPL Replimune Group | Upgraded: Buy | $17 | $10.23 | +66.18% | 33 | Jun 30, 2026 | |
| CAMP Camp4 Therapeutics | Upgraded: Buy | $9 | $3.71 | +142.59% | 3 | Jun 22, 2026 | |
| OLMA Olema Pharmaceuticals | Maintained: Buy | n/a | $11.47 | - | 28 | Jun 9, 2026 | |
| FULC Fulcrum Therapeutics | Downgraded: Sell | n/a | $3.65 | - | 5 | Jun 2, 2026 | |
| COGT Cogent Biosciences | Maintained: Buy | n/a | $39.08 | - | 16 | May 31, 2026 | |
| TVTX Travere Therapeutics | Maintained: Buy | $54 → $53 | $56.71 | -6.54% | 19 | May 29, 2026 | |
| IDYA IDEAYA Biosciences | Maintained: Buy | $81 → $66 | $36.01 | +83.28% | 37 | May 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $69 → $70 | $58.00 | +20.69% | 34 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 | $20.20 | +33.66% | 21 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $11 | $8.72 | +26.15% | 16 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $86 | $38.50 | +123.38% | 32 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $53 | $28.12 | +88.48% | 11 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $18 → $19 | $17.22 | +10.34% | 63 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $56 | $42.64 | +31.33% | 21 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $19.17 | +19.98% | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $100 | $81.38 | +22.88% | 42 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $177 → $185 | $170.88 | +8.26% | 64 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $72 | $63.95 | +12.59% | 24 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $10.73 | - | 30 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $1.62 | - | 5 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.28 | - | 2 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.80 | - | 20 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 → $12 | $3.62 | +231.49% | 12 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $45 | $22.80 | +97.37% | 24 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $13.74 | +38.28% | 3 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $12.04 | +165.78% | 1 | Mar 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $18.09 | +121.12% | 2 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $6 | $8.21 | -26.92% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.42 | n/a | 5 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $204 → $170 | $267.47 | n/a | 14 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $4.38 | n/a | 11 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27 → $5 | $8.39 | n/a | 6 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 → $64 | $80.18 | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $26 | $3.95 | n/a | 6 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $48 | $39.61 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $100.23 | n/a | 3 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $45 | $140.91 | n/a | 6 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.83 | n/a | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $16.93 | n/a | 7 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $55 | $52.86 | n/a | 2 | Nov 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $30 → $37 | $9.43 | n/a | 6 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $6 | $0.0001 | n/a | 8 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $56 → $10 | $12.25 | n/a | 5 | Mar 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $23.74 | n/a | 1 | Oct 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $1.86 | n/a | 2 | Jun 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $6 | $40.54 | n/a | 9 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $78.59 | n/a | 10 | Nov 16, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $124.37 | n/a | 1 | Sep 29, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $19 | $3.86 | n/a | 10 | Jul 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $17.32 | n/a | 4 | Jun 15, 2016 |
Kardigan
Jul 13, 2026
Initiated Coverage: Buy
Price Target: $51
Current: $21.13
Upside: +141.36%
First Tracks Biotherapeutics
Jul 9, 2026
Reiterated: Buy
Price Target: $30
Current: $36.52
Upside: -17.84%
Ultragenyx Pharmaceutical
Jul 7, 2026
Maintained: Buy
Price Target: $72
Current: $29.28
Upside: +145.90%
Replimune Group
Jun 30, 2026
Upgraded: Buy
Price Target: $17
Current: $10.23
Upside: +66.18%
Camp4 Therapeutics
Jun 22, 2026
Upgraded: Buy
Price Target: $9
Current: $3.71
Upside: +142.59%
Olema Pharmaceuticals
Jun 9, 2026
Maintained: Buy
Price Target: n/a
Current: $11.47
Upside: -
Fulcrum Therapeutics
Jun 2, 2026
Downgraded: Sell
Price Target: n/a
Current: $3.65
Upside: -
Cogent Biosciences
May 31, 2026
Maintained: Buy
Price Target: n/a
Current: $39.08
Upside: -
Travere Therapeutics
May 29, 2026
Maintained: Buy
Price Target: $54 → $53
Current: $56.71
Upside: -6.54%
IDEAYA Biosciences
May 29, 2026
Maintained: Buy
Price Target: $81 → $66
Current: $36.01
Upside: +83.28%
May 22, 2026
Maintained: Buy
Price Target: $69 → $70
Current: $58.00
Upside: +20.69%
May 22, 2026
Maintained: Buy
Price Target: $27
Current: $20.20
Upside: +33.66%
May 22, 2026
Maintained: Buy
Price Target: $12 → $11
Current: $8.72
Upside: +26.15%
May 22, 2026
Maintained: Buy
Price Target: $90 → $86
Current: $38.50
Upside: +123.38%
May 22, 2026
Maintained: Buy
Price Target: $58 → $53
Current: $28.12
Upside: +88.48%
May 18, 2026
Maintained: Hold
Price Target: $18 → $19
Current: $17.22
Upside: +10.34%
May 13, 2026
Maintained: Buy
Price Target: $60 → $56
Current: $42.64
Upside: +31.33%
May 13, 2026
Maintained: Buy
Price Target: $23
Current: $19.17
Upside: +19.98%
May 12, 2026
Maintained: Buy
Price Target: $94 → $100
Current: $81.38
Upside: +22.88%
May 8, 2026
Rated: Buy
Price Target: $177 → $185
Current: $170.88
Upside: +8.26%
May 4, 2026
Maintained: Buy
Price Target: $68 → $72
Current: $63.95
Upside: +12.59%
Apr 13, 2026
Maintained: Buy
Price Target: n/a
Current: $10.73
Upside: -
Mar 25, 2026
Maintained: Hold
Price Target: n/a
Current: $1.62
Upside: -
Mar 24, 2026
Maintained: Sell
Price Target: n/a
Current: $1.28
Upside: -
Mar 18, 2026
Maintained: Buy
Price Target: n/a
Current: $5.80
Upside: -
Mar 16, 2026
Upgraded: Buy
Price Target: $7 → $12
Current: $3.62
Upside: +231.49%
Mar 9, 2026
Maintained: Buy
Price Target: $33 → $45
Current: $22.80
Upside: +97.37%
Mar 3, 2026
Maintained: Buy
Price Target: $19
Current: $13.74
Upside: +38.28%
Mar 3, 2026
Initiated Coverage: Buy
Price Target: $32
Current: $12.04
Upside: +165.78%
Dec 18, 2025
Maintained: Buy
Price Target: $40
Current: $18.09
Upside: +121.12%
Nov 18, 2025
Maintained: Sell
Price Target: $6
Current: $8.21
Upside: -26.92%
May 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $16.42
Upside: n/a
Feb 1, 2024
Maintained: Hold
Price Target: $204 → $170
Current: $267.47
Upside: n/a
Dec 22, 2023
Downgraded: Sell
Price Target: n/a
Current: $4.38
Upside: n/a
Aug 15, 2022
Maintained: Hold
Price Target: $27 → $5
Current: $8.39
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $55 → $64
Current: $80.18
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $31 → $26
Current: $3.95
Upside: n/a
May 10, 2022
Maintained: Hold
Price Target: $50 → $48
Current: $39.61
Upside: n/a
May 10, 2022
Maintained: Buy
Price Target: $9 → $8
Current: $100.23
Upside: n/a
May 6, 2022
Maintained: Buy
Price Target: $51 → $45
Current: $140.91
Upside: n/a
Mar 8, 2022
Downgraded: Hold
Price Target: n/a
Current: $4.83
Upside: n/a
Feb 25, 2022
Maintained: Hold
Price Target: $12 → $13
Current: $16.93
Upside: n/a
Nov 12, 2021
Maintained: Buy
Price Target: $55
Current: $52.86
Upside: n/a
Oct 25, 2021
Upgraded: Hold
Price Target: $30 → $37
Current: $9.43
Upside: n/a
Aug 5, 2021
Upgraded: Buy
Price Target: $6
Current: $0.0001
Upside: n/a
Mar 25, 2021
Downgraded: Sell
Price Target: $56 → $10
Current: $12.25
Upside: n/a
Oct 12, 2020
Initiated Coverage: Buy
Price Target: $27
Current: $23.74
Upside: n/a
Jun 5, 2019
Downgraded: Sell
Price Target: n/a
Current: $1.86
Upside: n/a
Mar 1, 2019
Maintained: Buy
Price Target: $7 → $6
Current: $40.54
Upside: n/a
Nov 16, 2017
Upgraded: Hold
Price Target: n/a
Current: $78.59
Upside: n/a
Sep 29, 2017
Maintained: Hold
Price Target: n/a
Current: $124.37
Upside: n/a
Jul 21, 2017
Downgraded: Hold
Price Target: $20 → $19
Current: $3.86
Upside: n/a
Jun 15, 2016
Maintained: Hold
Price Target: n/a
Current: $17.32
Upside: n/a